Journal article Published 2022

Lipidomic profiling of human serum enables detection of pancreatic cancer

D. Wolrab, R. Jirasko, E. Cifkova, M. Horing, D. Mei, M. Chocholouskova, O. Peterka, J. Idowiak, T. Hrnciarova, L. Kuchar, R. Ahrends, Radana Brumarová, David Friedecký, G. Vivo-Truyols, P. Skrha,

Show all 27 authors

J. Skrha, R. Kucera, Bohuslav Melichar, G. Liebisch, R. Burkhardt, M.R. Wenk, A. Cazenave-Gassiot, P. Karasek, I. Novotny, K. Greplova, Roman Hrstka, M. Holcapek

Nature Communications 13(1), 124 (2022)

View on PubMed Cite

2022 Year
35013261 PMID

Cite this publication

WOLRAB, D., R. JIRASKO, E. CIFKOVA, M. HORING, D. MEI, M. CHOCHOLOUSKOVA, O. PETERKA, J. IDOWIAK, T. HRNCIAROVA, L. KUCHAR, R. AHRENDS, R. BRUMAROVÁ, D. FRIEDECKÝ, G. VIVO-TRUYOLS, P. SKRHA, J. SKRHA, R. KUCERA, B. MELICHAR, G. LIEBISCH, R. BURKHARDT, M. WENK, A. CAZENAVE-GASSIOT, P. KARASEK, I. NOVOTNY, K. GREPLOVA, R. HRSTKA, M. HOLCAPEK: Lipidomic profiling of human serum enables detection of pancreatic cancer. Nature Communications. 2022, 13(1), 124, ISSN: 2041-1723, PMID: 35013261.

Cite this publication

Details